Assessment of sleep quality, anxiety, depression, and quality of life in Behçet’s disease

The Egyptian Journal of Bronchology

Table 12 Correlation of disease duration, disease severity, VDI, and BDCAF with SF-36 domains for Behçet’s Disease group (n = 30)

	Disease Duration		Clinical Severity Score		VDI		BDCAF
	r	P	R	P	r	P	r	P
Physical functioning	-0.184	0.436	-0.704	< 0.001*	-0.534	0.002*	-0.735	< 0.001*
Role-physical	-0.224	0.235	-0.546	0.002*	-0.427	0.019*	-0.633	< 0.001*
Role-emotional	0.070	0.712	-0.277	0.139	-0.238	0.206	-0.387	0.035*
Energy/ fatigue	-0.262	0.162	-0.547	0.002*	-0.527	0.003*	-0.603	< 0.001*
Emotional wellbeing	-0.229	0.223	-0.729	< 0.001*	-0.687	< 0.001*	-0.753	< 0.001*
Social functioning	-0.015	0.938	-0.618	< 0.001*	-0.550	0.002*	-0.718	< 0.001*
Pain	-0.333	0.072	-0.549	0.002*	-0.414	0.023*	-0.655	< 0.001*
General Health	-0.172	0.364	-0.746	< 0.001*	-0.655	< 0.001*	-0.759	< 0.001*

Correlation for variables in the study was determined with spearman’s correlation. r Correlation coefficient rho. P-value: was significant if < 0.05. Clinical Severity score Krause’s Behçet’s disease activity assessment, VDI Vasculitis damage index, BDCAF: Behçet's Disease Current Activity Form, SF-36 The Short Form (36) Health Survey. Role-physical Role limitations due to physical health, Role-emotional Role limitations due to emotional problem